Head, Oncology Deparment
Bon Animal Medical Center
Suwon, Kyonggi-do, Republic of Korea
Dr. Doyun Kim, DVM, PhD, is a clinician-scientist in veterinary oncology whose work focuses on the real-world application of targeted therapies in dogs and cats.
He has published a prospective clinical study evaluating Sorafenib in dogs with advanced carcinomas in Veterinary and Comparative Oncology, and has led a study of Lapatinib in dogs with metastatic mammary gland tumors.
His research integrates clinical outcomes with biomarker-based approaches to guide patient-specific treatment decisions in clinical practice.
Disclosure information not submitted.
Transitioning from Tyrosine Kinase Inhibitors to Precision Oncology
Saturday, June 13, 2026
8:00 AM - 9:00 AM PT